Soft Start For $10B-Plus M&A Deals In 2026 [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
The cash-and-stock deal values Penumbra at $374 per share and will offer $11 billion in cash and roughly $4 billion in Boston Scientific stock, a roughly 73% cash to 27% stock mix, according to a Boston Scientific investor presentation. Boston Scientific-Penumbra falls in the middle of the pack of healthcare M&A deals with transaction values of more than $10 billion announced in the past five years. Getty Images A single M&A deal with a transaction value of more than $10 billion was announced in January, the lowest monthly large deal count since August 2024. After a surge of $10 billion-plus deal announcements in 2025, January 2026 had This article was written by Quick Insights The deal enables BSX to enter new vascular segments and high-growth therapeutic areas where it previously lacked offerings, leveraging PEN's novel technologies. The $14.56B deal is financed with $11B in cash—sourced from cash on hand and new debt—and $4B in BSX stock, a 73%/27% mix. PEN will
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific (BSX) Valuation After Mixed Q4 2025 Results And 2026 Growth Outlook [Yahoo! Finance]Yahoo! Finance
- Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Boston Scientific to participate in TD Cowen's 46th Annual Health Care ConferencePR Newswire
- Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBusiness Wire
- Boston Scientific Corporation (BSX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationBusiness Wire
BSX
Earnings
- 2/4/26 - Beat
BSX
Sec Filings
- 2/5/26 - Form 8-K
- 2/4/26 - Form 8-K
- 2/3/26 - Form 4
- BSX's page on the SEC website